Breaking News Instant updates and real-time market news.

MDT

Medtronic

$81.88

-1.645 (-1.97%)

, DXCM

Dexcom

$73.06

-0.14 (-0.19%)

10:34
08/22/17
08/22
10:34
08/22/17
10:34

Medtronic challenges in diabetes good news for Dexcom, Tandem, says JPMorgan

JPMorgan analyst Michael Weinstein noted that Medtronic (MDT) guided for its diabetes revenues to be down sequentially in the second and third quarters and lowered its diabetes growth guidance for the year. He said Medtronic's challenges "are naturally competitors' gains," and tells investors that he expects Dexcom (DXCM) and Tandem Diabetes (TNDM) to respond favorably to the news. Weinstein has an Overweight rating on Dexcom shares.

MDT

Medtronic

$81.88

-1.645 (-1.97%)

DXCM

Dexcom

$73.06

-0.14 (-0.19%)

TNDM

TNDM

  • 22

    Aug

  • 22

    Aug

  • 06

    Sep

  • 07

    Sep

  • 20

    Sep

MDT Medtronic
$81.88

-1.645 (-1.97%)

08/22/17
COWN
08/22/17
NO CHANGE
Target $95
COWN
Outperform
Medtronic positioned to bounce off of Q1 slowdown, says Cowen
Cowen analyst Joshua Jennings noted Medtronic's recent top-line momentum was thwarted by an IT problem and capacity constraint in Diabetes, but he believes organic revenue growth should rebound to the roughly 4% range. He cited soft comps and a tailwind from the Supplies divestiture. Jennings reiterated his Outperform rating and $95 price target on Medtronic shares.
07/06/17
07/06/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Nike (NKE) initiated with an Outperform at Raymond James. 2. JPMorgan (JPM) initiated with a Neutral at Goldman Sachs. 3. At Home Group (HOME) initiated with a Buy at SunTrust. 4. Logitech (LOGI) initiated with a Buy at Citi. 5. Medtronic (MDT) initiated with an Outperform at William Blair. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/31/17
DBAB
07/31/17
NO CHANGE
Target $96
DBAB
Buy
Medtronic attractive following share underperformance, says Deutsche Bank
Deutsche Bank analyst Brittany Henderson believes Medtronic shares represent an attractive investment opportunity after underperforming the broader S&P 500 medical supplies and devices index over the last 12 months. The company is well positioned for the "changing dynamics of the global healthcare environment," Henderson tells investors in a research note tilted "It is Time to Appreciate the Margin Expansion Story; Buy." She views the company as a mid-single digit sales and double digit earnings grower. The analyst reiterates a Buy rating on Medtronic with a $96 price target.
08/16/17
PIPR
08/16/17
NO CHANGE
Target $87
PIPR
Overweight
Piper calls Dexcom fears overblown, ups price target to $87
After analyzing the impact of Abbott's (ABT) FreeStyle Libre approval and Medtronic's (MDT) 670G rollout, Piper Jaffray analyst Matt O'Brien believes competitive fears for Dexcom (DXCM) are overblown. The ultimate impact on Dexcom from these technologies "will be less than feared" as FreeStlye Libre is unlikely to get a non-adjunctive claim and the 670G roll out will be slower than expected, O'Brien tells investors in a research note. He expects this to drive multiple expansion for Dexcom shares. The analyst upped his price target for the stock to $87 from $78 and keeps an Overweight rating on the name.
DXCM Dexcom
$73.06

-0.14 (-0.19%)

08/02/17
SPHN
08/02/17
NO CHANGE
Target $83
SPHN
Overweight
Dexcom price target lowered to $83 from $95 at Stephens
Stephens analyst Chris Cooley lowered his price target for Dexcom to $83 from $95 after the company reported Q2 operating results. The analyst reiterates an Overweight rating on the shares.
07/13/17
BTIG
07/13/17
NO CHANGE
BTIG
Buy
Abbott, Bigfoot deal a 'major validation' for both, says BTIG
BTIG analyst Sean Lavin sees Abbott's (ABT) deal to collaborate with Bigfoot Biomedical as a major validation of both Abbott's Libre technology and the platform of Bigfoot, which he views as a leader in the development of automated pancreases. For Dexcom (DXCM), this is a missed opportunity that could also be a sign that its grip on the CGM market may fade over time, but the company still has multiple shots with other pump systems and remains the market leader of standalone CGM, said Lavin. Insulet (PODD) is well underway in developing its Horizon AP platform and is unlikely to switch from Dexcom for its CGM, added Lavin, who keeps a Buy rating on Abbott and a Neutral rating on Dexcom.
08/02/17
OPCO
08/02/17
NO CHANGE
Target $92
OPCO
Outperform
Dexcom price target lowered to $92 from $98 at Oppenheimer
Oppenheimer analyst Steven Lichtman lowered his price target for Dexcom to $92 from $98 on reduced sales offset by recent peer multiple appreciation. The analyst reiterates an Outperform rating on the shares.
TNDM TNDM

11/03/16
PIPR
11/03/16
DOWNGRADE
Target $2.5
PIPR
Neutral
Tandem Diabetes downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Brooks West downgraded Tandem Diabetes (TNDM) to Neutral with a $2.50 price target following the Q3 miss citing low visibility and increased competitive headwinds from Medtronic's (MDT) 630G/670G launch.
03/24/17
RILY
03/24/17
DOWNGRADE
Target $1.5
RILY
Neutral
Tandem Diabetes downgraded to Neutral from Buy at B. Riley
B. Riley analyst Greg Chodaczek downgraded Tandem Diabetes to Neutral citing a weakening balance sheet. The "weak" equity offering shows a lack of institutional investor demand, the analyst contends. He cut his price target for the shares to $1.50 from $5.
03/30/17
PIPR
03/30/17
INITIATION
Target $1.5
PIPR
Neutral
Tandem Diabetes assumed with a Neutral at Piper Jaffray
Piper Jaffray analyst Matt O'Brien assumed coverage of Tandem Diabetes with a Neutral rating and $1.50 price target.
04/10/17
COWN
04/10/17
DOWNGRADE
COWN
Market Perform
Tandem Diabetes downgraded to Market Perform from Outperform at Cowen

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

13:17
09/19/17
09/19
13:17
09/19/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
09/19/17
09/19
13:16
09/19/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCA

HCA Holdings

$76.15

-1.53 (-1.97%)

13:15
09/19/17
09/19
13:15
09/19/17
13:15
Options
HCA Holdings put volume heavy and directionally bearish »

Bearish flow noted in HCA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
09/19/17
09/19
13:15
09/19/17
13:15
General news
Fed Policy Outlook: FOMC began its 2-day meeting »

Fed Policy Outlook: FOMC…

ICPT

Intercept

$95.75

0.87 (0.92%)

13:11
09/19/17
09/19
13:11
09/19/17
13:11
Conference/Events
Intercept management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

WHR

Whirlpool

$170.86

0.02 (0.01%)

13:10
09/19/17
09/19
13:10
09/19/17
13:10
Hot Stocks
Whirlpool ticks lower after August appliance data »

Shares of Whirlpool moved…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIF

Tiffany

$90.95

1.98 (2.23%)

13:05
09/19/17
09/19
13:05
09/19/17
13:05
Options
Tiffany call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 04

    Oct

13:00
09/19/17
09/19
13:00
09/19/17
13:00
General news
FOMC forecast revisions »

FOMC forecast revisions…

PTLA

Portola Pharmaceuticals

$56.57

1.62 (2.95%)

12:58
09/19/17
09/19
12:58
09/19/17
12:58
Recommendations
Portola Pharmaceuticals analyst commentary  »

Portola selloff today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

KR

Kroger

$21.29

-0.1501 (-0.70%)

12:55
09/19/17
09/19
12:55
09/19/17
12:55
Options
Kroger put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Oct

  • 30

    Nov

PTLA

Portola Pharmaceuticals

$56.57

1.62 (2.95%)

12:51
09/19/17
09/19
12:51
09/19/17
12:51
Recommendations
Portola Pharmaceuticals analyst commentary  »

Portola Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

FCAU

Fiat Chrysler

$17.10

0.275 (1.64%)

12:49
09/19/17
09/19
12:49
09/19/17
12:49
Hot Stocks
FCA US recalling 443,712 U.S.-market heavy-duty pickups, medium-duty trucks »

FCA US LLC is voluntarily…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$75.16

-0.15 (-0.20%)

12:48
09/19/17
09/19
12:48
09/19/17
12:48
Hot Stocks
Microsoft Azure IP Advantage available in China on October 1 »

Microsoft said on its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 22

    Oct

AA

Alcoa

$45.77

0.86 (1.91%)

12:45
09/19/17
09/19
12:45
09/19/17
12:45
Options
Alcoa call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDLS

Noodles & Company

$4.15

-0.25 (-5.68%)

12:37
09/19/17
09/19
12:37
09/19/17
12:37
Conference/Events
Noodles & Company management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

ENDP

Endo

$8.34

-0.26 (-3.02%)

, JNJ

Johnson & Johnson

$135.14

-0.24 (-0.18%)

12:37
09/19/17
09/19
12:37
09/19/17
12:37
Hot Stocks
Schneiderman, coalition of AGs expand multistate probe into opioid crisis »

New York Attorney General…

ENDP

Endo

$8.34

-0.26 (-3.02%)

JNJ

Johnson & Johnson

$135.14

-0.24 (-0.18%)

TEVA

Teva

$17.14

0.15 (0.88%)

AGN

Allergan

$218.48

-3.06 (-1.38%)

ABC

AmerisourceBergen

$80.24

-0.43 (-0.53%)

CAH

Cardinal Health

$66.37

-0.7 (-1.04%)

MCK

McKesson

$150.02

1.6 (1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Sep

  • 22

    Sep

  • 25

    Sep

  • 27

    Sep

  • 17

    Oct

LXRX

Lexicon

$12.81

0.44 (3.56%)

, IPSEY

Ipsen

$33.04

-0.36 (-1.08%)

12:37
09/19/17
09/19
12:37
09/19/17
12:37
Hot Stocks
Lexicon announces European Commission approves Xermelo »

Lexicon Pharmaceuticals…

LXRX

Lexicon

$12.81

0.44 (3.56%)

IPSEY

Ipsen

$33.04

-0.36 (-1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

12:35
09/19/17
09/19
12:35
09/19/17
12:35
General news
Today's U.S. reports »

Today's U.S. reports…

LEG

Leggett & Platt

$45.25

-0.635 (-1.38%)

12:34
09/19/17
09/19
12:34
09/19/17
12:34
Conference/Events
Leggett & Platt management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

AMZN

Amazon.com

$974.19

-12.6 (-1.28%)

, VIA

Viacom

$37.45

-0.4 (-1.06%)

12:32
09/19/17
09/19
12:32
09/19/17
12:32
Periodicals
Viacom leak may have compromised digital properties, Gizmodo reports »

A security researcher…

AMZN

Amazon.com

$974.19

-12.6 (-1.28%)

VIA

Viacom

$37.45

-0.4 (-1.06%)

VIAB

Viacom

$27.32

-0.35 (-1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

ACTG

Acacia Research

12:32
09/19/17
09/19
12:32
09/19/17
12:32
Hot Stocks
Acacia Research shares trade higher amid insider buying »

A number of insiders at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDOT

Green Dot

$48.82

0.79 (1.64%)

12:30
09/19/17
09/19
12:30
09/19/17
12:30
Conference/Events
Green Dot management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

ADBE

Adobe

$155.77

1.28 (0.83%)

12:30
09/19/17
09/19
12:30
09/19/17
12:30
Options
Adobe attracts a pre-earnings call writer »

Adobe attracts a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 22

    Oct

ENDP

Endo

$8.34

-0.26 (-3.02%)

, JNJ

Johnson & Johnson

$134.95

-0.43 (-0.32%)

12:28
09/19/17
09/19
12:28
09/19/17
12:28
Hot Stocks
Michigan AG says 41 state attorneys general now involved in opioid probe »

Michigan Attorney General…

ENDP

Endo

$8.34

-0.26 (-3.02%)

JNJ

Johnson & Johnson

$134.95

-0.43 (-0.32%)

TEVA

Teva

$17.14

0.15 (0.88%)

AGN

Allergan

$218.49

-3.05 (-1.38%)

ABC

AmerisourceBergen

$80.20

-0.47 (-0.58%)

CAH

Cardinal Health

$66.36

-0.71 (-1.06%)

MCK

McKesson

$149.89

1.47 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Sep

  • 22

    Sep

  • 25

    Sep

  • 27

    Sep

  • 17

    Oct

EFX

Equifax

$94.55

0.17 (0.18%)

12:27
09/19/17
09/19
12:27
09/19/17
12:27
Periodicals
Massachusetts Attorney General files lawsuit against Equifax, Reuters reports »

The State of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.